{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:25:05Z","timestamp":1767893105090,"version":"3.49.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T00:00:00Z","timestamp":1547856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Chinese national natural science foundation","doi-asserted-by":"crossref","award":["81673970"],"award-info":[{"award-number":["81673970"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Chinese national natural science foundation","doi-asserted-by":"crossref","award":["81874449"],"award-info":[{"award-number":["81874449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10753-019-00959-6","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T00:22:12Z","timestamp":1547857332000},"page":"790-798","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Review: the Roles and Mechanisms of Glycoprotein 130 Cytokines in the Regulation of Adipocyte Biological Function"],"prefix":"10.1007","volume":"42","author":[{"given":"Dufang","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guofeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongcheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,19]]},"reference":[{"issue":"4","key":"959_CR1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/138161211795164202","volume":"17","author":"UA White","year":"2011","unstructured":"White, U.A., and J.M. Stephens. 2011. The gp130 receptor cytokine family: Regulators of adipocyte development and function. Current Pharmaceutical Design 17 (4): 340\u2013346.","journal-title":"Current Pharmaceutical Design"},{"issue":"4","key":"959_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1254\/jphs.11R05CR","volume":"117","author":"Y Fujio","year":"2011","unstructured":"Fujio, Y., M. Maeda, T. Mohri, M. Obana, T. Iwakura, A. Hayama, T. Yamashita, H. Nakayama, and J. Azuma. 2011. Glycoprotein 130 cytokine signal as a therapeutic target against cardiovascular diseases. Journal of Pharmacological Sciences 117 (4): 213\u2013222.","journal-title":"Journal of Pharmacological Sciences"},{"issue":"1","key":"959_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tig.2003.11.003","volume":"20","author":"M Ernst","year":"2004","unstructured":"Ernst, M., and B.J. Jenkins. 2004. Acquiring signalling specificity from the cytokine receptor gp130. Trends in Genetics 20 (1): 23\u201332. \nhttps:\/\/doi.org\/10.1016\/j.tig.2003.11.003\n\n.","journal-title":"Trends in Genetics"},{"issue":"2","key":"959_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrendo.2016.211.","volume":"13","author":"S Kajimura","year":"2017","unstructured":"Kajimura, S. 2017. Adipose tissue in 2016: advances in the understanding of adipose tissue biology. Nature Reviews. Endocrinology 13 (2): 69\u201370. \nhttps:\/\/doi.org\/10.1038\/nrendo.2016.211.","journal-title":"Nature Reviews. Endocrinology"},{"key":"959_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.lfs.2017.08.008.","volume":"186","author":"S Murakami","year":"2017","unstructured":"Murakami, S. 2017. The physiological and pathophysiological roles of taurine in adipose tissue in relation to obesity. Life Sciences 186: 80\u201386. \nhttps:\/\/doi.org\/10.1016\/j.lfs.2017.08.008.","journal-title":"Life Sciences"},{"issue":"5","key":"959_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/oby.2010.293","volume":"19","author":"UA White","year":"2011","unstructured":"White, U.A., W.C. Stewart, and J.M. Stephens. 2011. Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo. Obesity (Silver Spring) 19 (5): 903\u2013910. \nhttps:\/\/doi.org\/10.1038\/oby.2010.293\n\n.","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"959_CR7","doi-asserted-by":"publisher","first-page":"E827","DOI":"10.1152\/ajpendo.2001.280.6.E827","volume":"280","author":"G Fruhbeck","year":"2001","unstructured":"Fruhbeck, G., J. Gomez-Ambrosi, F.J. Muruzabal, and M.A. Burrell. 2001. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. American Journal of Physiology. Endocrinology and Metabolism 280 (6): E827\u2013E847. \nhttps:\/\/doi.org\/10.1152\/ajpendo.2001.280.6.E827\n\n.","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"12","key":"959_CR8","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1210\/jcem.82.12.4450","volume":"82","author":"V Mohamed-Ali","year":"1997","unstructured":"Mohamed-Ali, V., S. Goodrick, A. Rawesh, D.R. Katz, J.M. Miles, J.S. Yudkin, S. Klein, and S.W. Coppack. 1997. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. The Journal of Clinical Endocrinology and Metabolism 82 (12): 4196\u20134200. \nhttps:\/\/doi.org\/10.1210\/jcem.82.12.4450\n\n.","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"5708","key":"959_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1104342","volume":"307","author":"MA Lazar","year":"2005","unstructured":"Lazar, M.A. 2005. How obesity causes diabetes: not a tall tale. Science 307 (5708): 373\u2013375. \nhttps:\/\/doi.org\/10.1126\/science.1104342\n\n.","journal-title":"Science"},{"issue":"5907","key":"959_CR10","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1126\/science.1160794","volume":"322","author":"G Sabio","year":"2008","unstructured":"Sabio, G., M. Das, A. Mora, Z. Zhang, J.Y. Jun, H.J. Ko, T. Barrett, J.K. Kim, and R.J. Davis. 2008. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322 (5907): 1539\u20131543. \nhttps:\/\/doi.org\/10.1126\/science.1160794\n\n.","journal-title":"Science"},{"issue":"11","key":"959_CR11","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.2337\/diabetes.52.11.2784","volume":"52","author":"PJ Klover","year":"2003","unstructured":"Klover, P.J., T.A. Zimmers, L.G. Koniaris, and R.A. Mooney. 2003. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52 (11): 2784\u20132789.","journal-title":"Diabetes"},{"issue":"6","key":"959_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0148607104028006410","volume":"28","author":"L Khaodhiar","year":"2004","unstructured":"Khaodhiar, L., P.R. Ling, G.L. Blackburn, and B.R. Bistrian. 2004. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. JPEN Journal of Parenteral and Enteral Nutrition 28 (6): 410\u2013415. \nhttps:\/\/doi.org\/10.1177\/0148607104028006410\n\n.","journal-title":"JPEN Journal of Parenteral and Enteral Nutrition"},{"issue":"9","key":"959_CR13","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1210\/jcem.85.9.6839","volume":"85","author":"JP Bastard","year":"2000","unstructured":"Bastard, J.P., C. Jardel, E. Bruckert, P. Blondy, J. Capeau, M. Laville, H. Vidal, and B. Hainque. 2000. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. The Journal of Clinical Endocrinology and Metabolism 85 (9): 3338\u20133342. \nhttps:\/\/doi.org\/10.1210\/jcem.85.9.6839\n\n.","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"11","key":"959_CR14","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s00125-010-1865-y.","volume":"53","author":"VB Matthews","year":"2010","unstructured":"Matthews, V.B., T.L. Allen, S. Risis, M.H. Chan, D.C. Henstridge, N. Watson, L.A. Zaffino, et al. 2010. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 53 (11): 2431\u20132441. \nhttps:\/\/doi.org\/10.1007\/s00125-010-1865-y.","journal-title":"Diabetologia"},{"issue":"1","key":"959_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm0102-75","volume":"8","author":"V Wallenius","year":"2002","unstructured":"Wallenius, V., K. Wallenius, B. Ahren, M. Rudling, H. Carlsten, S.L. Dickson, C. Ohlsson, and J.O. Jansson. 2002. Interleukin-6-deficient mice develop mature-onset obesity. Nature Medicine 8 (1): 75\u201379. \nhttps:\/\/doi.org\/10.1038\/nm0102-75\n\n.","journal-title":"Nature Medicine"},{"issue":"5","key":"959_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ni.2865.","volume":"15","author":"J Mauer","year":"2014","unstructured":"Mauer, J., B. Chaurasia, J. Goldau, M.C. Vogt, J. Ruud, K.D. Nguyen, S. Theurich, A.C. Hausen, J. Schmitz, H.S. Br\u00f6nneke, E. Estevez, T.L. Allen, A. Mesaros, L. Partridge, M.A. Febbraio, A. Chawla, F.T. Wunderlich, and J.C. Br\u00fcning. 2014. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nature Immunology 15 (5): 423\u2013430. \nhttps:\/\/doi.org\/10.1038\/ni.2865.","journal-title":"Nature Immunology"},{"issue":"5","key":"959_CR17","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller, J., A. Chalaris, D. Schmidt-Arras, and S. Rose-John. 2011. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochimica et Biophysica Acta 1813 (5): 878\u2013888. \nhttps:\/\/doi.org\/10.1016\/j.bbamcr.2011.01.034\n\n.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"Suppl 3","key":"959_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/dom.12170","volume":"15","author":"MJ Kraakman","year":"2013","unstructured":"Kraakman, M.J., T.L. Allen, M. Whitham, P. Iliades, H.L. Kammoun, E. Estevez, G.I. Lancaster, and M.A. Febbraio. 2013. Targeting gp130 to prevent inflammation and promote insulin action. Diabetes, Obesity & Metabolism 15 (Suppl 3): 170\u2013175. \nhttps:\/\/doi.org\/10.1111\/dom.12170\n\n.","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"1","key":"959_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1046\/j.1432-1327.2001.01867.x","volume":"268","author":"T Jostock","year":"2001","unstructured":"Jostock, T., J. Mullberg, S. Ozbek, R. Atreya, G. Blinn, N. Voltz, M. Fischer, M.F. Neurath, and S. Rose-John. 2001. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. European Journal of Biochemistry 268 (1): 160\u2013167.","journal-title":"European Journal of Biochemistry"},{"issue":"3","key":"959_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cmet.2015.02.006","volume":"21","author":"MJ Kraakman","year":"2015","unstructured":"Kraakman, M.J., H.L. Kammoun, T.L. Allen, V. Deswaerte, D.C. Henstridge, E. Estevez, V.B. Matthews, B. Neill, D.A. White, A.J. Murphy, L. Peijs, C. Yang, S. Risis, C.R. Bruce, X.J. du, A. Bobik, R.S. Lee-Young, B.A. Kingwell, A. Vasanthakumar, W. Shi, A. Kallies, G.I. Lancaster, S. Rose-John, and M.A. Febbraio. 2015. Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance. Cell Metabolism 21 (3): 403\u2013416. \nhttps:\/\/doi.org\/10.1016\/j.cmet.2015.02.006\n\n.","journal-title":"Cell Metabolism"},{"issue":"4","key":"959_CR21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cmet.2013.06.016","volume":"18","author":"K Sun","year":"2013","unstructured":"Sun, K., J. Tordjman, K. Clement, and P.E. Scherer. 2013. Fibrosis and adipose tissue dysfunction. Cell Metabolism 18 (4): 470\u2013477. \nhttps:\/\/doi.org\/10.1016\/j.cmet.2013.06.016\n\n.","journal-title":"Cell Metabolism"},{"key":"959_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4485","volume":"5","author":"K Sun","year":"2014","unstructured":"Sun, K., J. Park, O.T. Gupta, W.L. Holland, P. Auerbach, N. Zhang, R. Goncalves Marangoni, S.M. Nicoloro, M.P. Czech, J. Varga, T. Ploug, Z. An, and P.E. Scherer. 2014. Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction. Nature Communications 5: 3485. \nhttps:\/\/doi.org\/10.1038\/ncomms4485\n\n.","journal-title":"Nature Communications"},{"issue":"5","key":"959_CR23","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1128\/mcb.00951-12","volume":"33","author":"K Sun","year":"2013","unstructured":"Sun, K., N. Halberg, M. Khan, U.J. Magalang, and P.E. Scherer. 2013. Selective inhibition of hypoxia-inducible factor 1alpha ameliorates adipose tissue dysfunction. Molecular and Cellular Biology 33 (5): 904\u2013917. \nhttps:\/\/doi.org\/10.1128\/mcb.00951-12\n\n.","journal-title":"Molecular and Cellular Biology"},{"issue":"2","key":"959_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.celrep.2017.03.043","volume":"19","author":"K Timper","year":"2017","unstructured":"Timper, K., J.L. Denson, S.M. Steculorum, C. Heilinger, L. Engstrom-Ruud, C.M. Wunderlich, S. Rose-John, F.T. Wunderlich, and J.C. Bruning. 2017. IL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling. Cell Reports 19 (2): 267\u2013280. \nhttps:\/\/doi.org\/10.1016\/j.celrep.2017.03.043\n\n.","journal-title":"Cell Reports"},{"key":"959_CR25","doi-asserted-by":"publisher","first-page":"970375","DOI":"10.1155\/2015\/970375","volume":"2015","author":"I Moreno-Indias","year":"2015","unstructured":"Moreno-Indias, I., and F.J. Tinahones. 2015. Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders. Journal Diabetes Research 2015: 970375. \nhttps:\/\/doi.org\/10.1155\/2015\/970375\n\n.","journal-title":"Journal Diabetes Research"},{"issue":"3","key":"959_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12020-008-9085-7","volume":"33","author":"Yongqing Yang","year":"2008","unstructured":"Yang, Y., D. Ju, M. Zhang, and G. Yang. 2008. Interleukin-6 stimulates lipolysis in porcine adipocytes. Endocrine 33 (3): 261\u2013269. \nhttps:\/\/doi.org\/10.1007\/s12020-008-9085-7\n\n.","journal-title":"Endocrine"},{"issue":"1","key":"959_CR27","doi-asserted-by":"publisher","first-page":"E155","DOI":"10.1152\/ajpendo.00257.2004","volume":"288","author":"EW Petersen","year":"2005","unstructured":"Petersen, E.W., A.L. Carey, M. Sacchetti, G.R. Steinberg, S.L. Macaulay, M.A. Febbraio, and B.K. Pedersen. 2005. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. American Journal of Physiology. Endocrinology and Metabolism 288 (1): E155\u2013E162. \nhttps:\/\/doi.org\/10.1152\/ajpendo.00257.2004\n\n.","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"3","key":"959_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011.","volume":"20","author":"M Petruzzelli","year":"2014","unstructured":"Petruzzelli, M., M. Schweiger, R. Schreiber, R. Campos-Olivas, M. Tsoli, J. Allen, M. Swarbrick, S. Rose-John, M. Rincon, G. Robertson, R. Zechner, and E.F. Wagner. 2014. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metabolism 20 (3): 433\u2013447. \nhttps:\/\/doi.org\/10.1016\/j.cmet.2014.06.011.","journal-title":"Cell Metabolism"},{"issue":"4","key":"959_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1160\/th13-04-0285.","volume":"110","author":"M Morelli","year":"2013","unstructured":"Morelli, M., M. Gaggini, G. Daniele, P. Marraccini, R. Sicari, and A. Gastaldelli. 2013. Ectopic fat: the true culprit linking obesity and cardiovascular disease? Thrombosis and Haemostasis 110 (4): 651\u2013660. \nhttps:\/\/doi.org\/10.1160\/th13-04-0285\n\n.","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"959_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1515\/hmbci-2015-0006","volume":"22","author":"M Gaggini","year":"2015","unstructured":"Gaggini, M., C. Saponaro, and A. Gastaldelli. 2015. Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases. Horm Mol Biol Clin Investig 22 (1): 7\u201318. \nhttps:\/\/doi.org\/10.1515\/hmbci-2015-0006\n\n.","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"8","key":"959_CR31","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tem.2016.06.006","volume":"27","author":"A Abdullahi","year":"2016","unstructured":"Abdullahi, A., and M.G. Jeschke. 2016. White Adipose Tissue Browning: A Double-edged Sword. Trends in Endocrinology and Metabolism 27 (8): 542\u2013552. \nhttps:\/\/doi.org\/10.1016\/j.tem.2016.06.006\n\n.","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"1","key":"959_CR32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/db15-0941.","volume":"65","author":"S Wueest","year":"2016","unstructured":"Wueest, S., F. Item, F.C. Lucchini, T.D. Challa, W. Muller, M. Bluher, and D. Konrad. 2016. Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance. Diabetes 65 (1): 140\u2013148. \nhttps:\/\/doi.org\/10.2337\/db15-0941.","journal-title":"Diabetes"},{"issue":"4","key":"959_CR33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cell.2015.01.012.","volume":"160","author":"RJ Perry","year":"2015","unstructured":"Perry, R.J., J.G. Camporez, R. Kursawe, P.M. Titchenell, D. Zhang, C.J. Perry, M.J. Jurczak, et al. 2015. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 160 (4): 745\u2013758. \nhttps:\/\/doi.org\/10.1016\/j.cell.2015.01.012.","journal-title":"Cell"},{"issue":"1","key":"959_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2337\/db17-0637","volume":"67","author":"S Wueest","year":"2018","unstructured":"Wueest, S., C.I. Laesser, M. Boni-Schnetzler, F. Item, F.C. Lucchini, M. Borsigova, W. Muller, M.Y. Donath, and D. Konrad. 2018. IL-6-Type Cytokine Signaling in Adipocytes Induces Intestinal GLP-1 Secretion. Diabetes 67 (1): 36\u201345. \nhttps:\/\/doi.org\/10.2337\/db17-0637\n\n.","journal-title":"Diabetes"},{"issue":"3","key":"959_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/21623945.2018.1493901","volume":"7","author":"S Wueest","year":"2018","unstructured":"Wueest, S., and D. Konrad. 2018. The role of adipocyte-specific IL-6-type cytokine signaling in FFA and leptin release. Adipocyte 7 (3): 226\u2013228. \nhttps:\/\/doi.org\/10.1080\/21623945.2018.1493901\n\n.","journal-title":"Adipocyte"},{"issue":"6","key":"959_CR36","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1349-7006.1997.tb00421.x","volume":"88","author":"Y Akiyama","year":"1997","unstructured":"Akiyama, Y., N. Kajimura, J. Matsuzaki, Y. Kikuchi, N. Imai, M. Tanigawa, and K. Yamaguchi. 1997. In vivo effect of recombinant human leukemia inhibitory factor in primates. Japanese Journal of Cancer Research 88 (6): 578\u2013583.","journal-title":"Japanese Journal of Cancer Research"},{"issue":"5","key":"959_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cytogfr.2015.07.001","volume":"26","author":"NA Nicola","year":"2015","unstructured":"Nicola, N.A., and J.J. Babon. 2015. Leukemia inhibitory factor (LIF). Cytokine & Growth Factor Reviews 26 (5): 533\u2013544. \nhttps:\/\/doi.org\/10.1016\/j.cytogfr.2015.07.001\n\n.","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"35","key":"959_CR38","doi-asserted-by":"publisher","first-page":"24965","DOI":"10.1074\/jbc.274.35.24965","volume":"274","author":"J Aubert","year":"1999","unstructured":"Aubert, J., S. Dessolin, N. Belmonte, M. Li, F.R. McKenzie, L. Staccini, P. Villageois, B. Barhanin, A. Vernallis, A.G. Smith, G. Ailhaud, and C. Dani. 1999. Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade. The Journal of Biological Chemistry 274 (35): 24965\u201324972.","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"959_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/jcb.240540113","volume":"54","author":"JM Gimble","year":"1994","unstructured":"Gimble, J.M., F. Wanker, C.S. Wang, H. Bass, X. Wu, K. Kelly, G.D. Yancopoulos, and M.R. Hill. 1994. Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein. Journal of Cellular Biochemistry 54 (1): 122\u2013133. \nhttps:\/\/doi.org\/10.1002\/jcb.240540113\n\n.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"3","key":"959_CR40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1677\/joe.1.05980","volume":"185","author":"J. C Hogan","year":"2005","unstructured":"Hogan, J.C., and J.M. Stephens. 2005. Effects of leukemia inhibitory factor on 3T3-L1 adipocytes. The Journal of Endocrinology 185 (3): 485\u2013496. \nhttps:\/\/doi.org\/10.1677\/joe.1.05980.","journal-title":"Journal of Endocrinology"},{"issue":"33","key":"959_CR41","doi-asserted-by":"publisher","first-page":"22505","DOI":"10.1074\/jbc.M710462200","volume":"283","author":"UA White","year":"2008","unstructured":"White, U.A., W.C. Stewart, R.L. Mynatt, and J.M. Stephens. 2008. Neuropoietin attenuates adipogenesis and induces insulin resistance in adipocytes. The Journal of Biological Chemistry 283 (33): 22505\u201322512. \nhttps:\/\/doi.org\/10.1074\/jbc.M710462200\n\n.","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"959_CR42","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0006-291X(89)80114-7","volume":"160","author":"M Mori","year":"1989","unstructured":"Mori, M., K. Yamaguchi, and K. Abe. 1989. Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia. Biochemical and Biophysical Research Communications 160 (3): 1085\u20131092.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"959_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1182\/blood.V76.1.50.50","volume":"76","author":"D Metcalf","year":"1990","unstructured":"Metcalf, D., N.A. Nicola, and D.P. Gearing. 1990. Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice. Blood 76 (1): 50\u201356.","journal-title":"Blood"},{"issue":"1","key":"959_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/endo.135.1.8013346","volume":"135","author":"M K Marshall","year":"1994","unstructured":"Marshall, M.K., W. Doerrler, K.R. Feingold, and C. Grunfeld. 1994. Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes. Endocrinology 135 (1): 141\u2013147. \nhttps:\/\/doi.org\/10.1210\/endo.135.1.8013346\n\n.","journal-title":"Endocrinology"},{"key":"959_CR45","doi-asserted-by":"publisher","unstructured":"Arora, G.K., A. Gupta, S. Narayanan, T. Guo, P. Iyengar, and R.E. Infante. 2018. Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin. JCI Insight 3 (14). \nhttps:\/\/doi.org\/10.1172\/jci.insight.121221\n\n.","DOI":"10.1172\/jci.insight.121221"},{"issue":"5","key":"959_CR46","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0196-9781(02)00021-9","volume":"23","author":"E Beretta","year":"2002","unstructured":"Beretta, E., H. Dhillon, P.S. Kalra, and S.P. Kalra. 2002. Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods. Peptides 23 (5): 975\u2013984.","journal-title":"Peptides"},{"issue":"2","key":"959_CR47","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1210\/en.2009-1135","volume":"151","author":"AJ Grossberg","year":"2010","unstructured":"Grossberg, A.J., J.M. Scarlett, X. Zhu, D.D. Bowe, A.K. Batra, T.P. Braun, and D.L. Marks. 2010. Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130. Endocrinology 151 (2): 606\u2013616. \nhttps:\/\/doi.org\/10.1210\/en.2009-1135\n\n.","journal-title":"Endocrinology"},{"key":"959_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neulet.2018.05.041","volume":"681","author":"S Lee","year":"2018","unstructured":"Lee, S., J. Lee, G.M. Kang, and M.S. Kim. 2018. Leptin directly regulate intrinsic neuronal excitability in hypothalamic POMC neurons but not in AgRP neurons in food restricted mice. Neuroscience Letters 681: 105\u2013109. \nhttps:\/\/doi.org\/10.1016\/j.neulet.2018.05.041\n\n.","journal-title":"Neuroscience Letters"},{"issue":"2","key":"959_CR49","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/ana.410390215","volume":"39","author":"Robert G. Miller","year":"1996","unstructured":"Miller, R.G., J.H. Petajan, W.W. Bryan, C. Armon, R.J. Barohn, J.C. Goodpasture, R.J. Hoagland, G.J. Parry, M.A. Ross, and S.C. Stromatt. 1996. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis rhCNTF ALS Study Group. Ann Neurol 39 (2): 256\u2013260. \nhttps:\/\/doi.org\/10.1002\/ana.410390215\n\n.","journal-title":"Annals of Neurology"},{"issue":"5","key":"959_CR50","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1212\/WNL.46.5.1244","volume":"46","author":"A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group","year":"1996","unstructured":"A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group. 1996. Neurology 46 (5): 1244\u20131249.","journal-title":"Neurology"},{"issue":"11","key":"959_CR51","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.2337\/diabetes.53.11.2787","volume":"53","author":"S Bluher","year":"2004","unstructured":"Bluher, S., S. Moschos, J. Bullen Jr., E. Kokkotou, E. Maratos-Flier, S.J. Wiegand, M.W. Sleeman, and C.S. Mantzoros. 2004. Ciliary neurotrophic factorAx15 alters energy homeostasis, decreases body weight, and improves metabolic control in diet-induced obese and UCP1-DTA mice. Diabetes 53 (11): 2787\u20132796.","journal-title":"Diabetes"},{"issue":"2","key":"959_CR52","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1677\/joe.0.173r001","volume":"173","author":"V Ott","year":"2002","unstructured":"Ott, V., M. Fasshauer, A. Dalski, H.H. Klein, and J. Klein. 2002. Direct effects of ciliary neurotrophic factor on brown adipocytes: evidence for a role in peripheral regulation of energy homeostasis. The Journal of Endocrinology 173 (2): R1\u2013R8.","journal-title":"The Journal of Endocrinology"},{"issue":"2","key":"959_CR53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1742-7843.2007.00092.x","volume":"101","author":"QS Liu","year":"2007","unstructured":"Liu, Q.S., M. Gao, S.Y. Zhu, S.J. Li, L. Zhang, Q.J. Wang, and G.H. Du. 2007. The novel mechanism of recombinant human ciliary neurotrophic factor on the anti-diabetes activity. Basic & Clinical Pharmacology & Toxicology 101 (2): 78\u201384. \nhttps:\/\/doi.org\/10.1111\/j.1742-7843.2007.00092.x\n\n.","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"issue":"5","key":"959_CR54","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1210\/en.2005-1074","volume":"147","author":"MJ Watt","year":"2006","unstructured":"Watt, M.J., A. Hevener, G.I. Lancaster, and M.A. Febbraio. 2006. Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating ceramide accumulation and phosphorylation of c-Jun N-terminal kinase in peripheral tissues. Endocrinology 147 (5): 2077\u20132085. \nhttps:\/\/doi.org\/10.1210\/en.2005-1074\n\n.","journal-title":"Endocrinology"},{"issue":"5","key":"959_CR55","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nm1383","volume":"12","author":"MJ Watt","year":"2006","unstructured":"Watt, M.J., N. Dzamko, W.G. Thomas, S. Rose-John, M. Ernst, D. Carling, B.E. Kemp, M.A. Febbraio, and G.R. Steinberg. 2006. CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nature Medicine 12 (5): 541\u2013548. \nhttps:\/\/doi.org\/10.1038\/nm1383\n\n.","journal-title":"Nature Medicine"},{"issue":"5","key":"959_CR56","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1023\/B:APPT.0000038042.31683.7b","volume":"9","author":"E. Duff","year":"2004","unstructured":"Duff, E., C.L. Li, D.L. Hartzell, Y.H. Choi, M.A. Della-Fera, and C.A. Baile. 2004. Ciliary neurotrophic factor injected icv induces adipose tissue apoptosis in rats. Apoptosis 9 (5): 629\u2013634. \nhttps:\/\/doi.org\/10.1023\/B:APPT.0000038042.31683.7b\n\n.","journal-title":"Apoptosis"},{"issue":"5748","key":"959_CR57","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1126\/science.1115360.","volume":"310","author":"MV Kokoeva","year":"2005","unstructured":"Kokoeva, M.V., H. Yin, and J.S. Flier. 2005. Neurogenesis in the hypothalamus of adult mice: potential role in energy balance. Science 310 (5748): 679\u2013683. \nhttps:\/\/doi.org\/10.1126\/science.1115360.","journal-title":"Science"},{"issue":"12","key":"959_CR58","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1006\/cyto.1996.0123.","volume":"8","author":"H Jin","year":"1996","unstructured":"Jin, H., R. Yang, G.A. Keller, A. Ryan, A. Ko, D. Finkle, T.A. Swanson, W. Li, D. Pennica, W.I. Wood, and N.F. Paoni. 1996. In vivo effects of cardiotrophin-1. Cytokine 8 (12): 920\u2013926. \nhttps:\/\/doi.org\/10.1006\/cyto.1996.0123.","journal-title":"Cytokine"},{"issue":"46","key":"959_CR59","doi-asserted-by":"publisher","first-page":"47572","DOI":"10.1074\/jbc.M403998200","volume":"279","author":"S Zvonic","year":"2004","unstructured":"Zvonic, S., J.C. Hogan, P. Arbour-Reily, R.L. Mynatt, and J.M. Stephens. 2004. Effects of cardiotrophin on adipocytes. The Journal of Biological Chemistry 279 (46): 47572\u201347579. \nhttps:\/\/doi.org\/10.1074\/jbc.M403998200\n\n.","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"959_CR60","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cmet.2011.05.013","volume":"14","author":"MJ Moreno-Aliaga","year":"2011","unstructured":"Moreno-Aliaga, M.J., N. Perez-Echarri, B. Marcos-Gomez, E. Larequi, F.J. Gil-Bea, B. Viollet, I. Gimenez, J.A. Martinez, J. Prieto, and M. Bustos. 2011. Cardiotrophin-1 is a key regulator of glucose and lipid metabolism. Cell Metabolism 14 (2): 242\u2013253. \nhttps:\/\/doi.org\/10.1016\/j.cmet.2011.05.013\n\n.","journal-title":"Cell Metabolism"},{"issue":"12","key":"959_CR61","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1194\/jlr.M055335","volume":"55","author":"M Lopez-Yoldi","year":"2014","unstructured":"Lopez-Yoldi, M., M. Fernandez-Galilea, L.M. Laiglesia, E. Larequi, J. Prieto, J.A. Martinez, M. Bustos, and M.J. Moreno-Aliaga. 2014. Cardiotrophin-1 stimulates lipolysis through the regulation of main adipose tissue lipases. Journal of Lipid Research 55 (12): 2634\u20132643. \nhttps:\/\/doi.org\/10.1194\/jlr.M055335\n\n.","journal-title":"Journal of Lipid Research"},{"issue":"9","key":"959_CR62","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/jcp.25590","volume":"232","author":"M Lopez-Yoldi","year":"2017","unstructured":"Lopez-Yoldi, M., B. Marcos-Gomez, M.A. Romero-Lozano, N. Sainz, J. Prieto, J.A. Martinez, M. Bustos, and M.J. Moreno-Aliaga. 2017. Cardiotrophin-1 Regulates Adipokine Production in 3T3-L1 Adipocytes and Adipose Tissue From Obese Mice. Journal of Cellular Physiology 232 (9): 2469\u20132477. \nhttps:\/\/doi.org\/10.1002\/jcp.25590\n\n.","journal-title":"Journal of Cellular Physiology"},{"issue":"1\u20132","key":"959_CR63","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11010-011-0799-0.","volume":"353","author":"S Zhu","year":"2011","unstructured":"Zhu, S., F. Sun, W. Li, Y. Cao, C. Wang, Y. Wang, D. Liang, R. Zhang, S. Zhang, H. Wang, and F. Cao. 2011. Apelin stimulates glucose uptake through the PI3K\/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes. Molecular and Cellular Biochemistry 353 (1\u20132): 305\u2013313. \nhttps:\/\/doi.org\/10.1007\/s11010-011-0799-0\n\n.","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"4","key":"959_CR64","doi-asserted-by":"publisher","first-page":"635","DOI":"10.5114\/aoms.2013.37272","volume":"9","author":"U Vespasiani-Gentilucci","year":"2013","unstructured":"Vespasiani-Gentilucci, U., A. De Vincentis, J. Argemi, G. Galati, E. Anso, G. Patti, and A. Picardi. 2013. Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography. Archives of Medical Science 9 (4): 635\u2013639. \nhttps:\/\/doi.org\/10.5114\/aoms.2013.37272\n\n.","journal-title":"Archives of Medical Science"},{"issue":"3","key":"959_CR65","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.ijcard.2013.08.112","volume":"169","author":"HC Hung","year":"2013","unstructured":"Hung, H.C., F.H. Lu, H.Y. Ou, H.T. Wu, J.S. Wu, Y.C. Yang, and C.J. Chang. 2013. Increased cardiotrophin-1 in subjects with impaired glucose tolerance and newly diagnosed diabetes. International Journal of Cardiology 169 (3): e33\u2013e34. \nhttps:\/\/doi.org\/10.1016\/j.ijcard.2013.08.112\n\n.","journal-title":"International Journal of Cardiology"},{"key":"959_CR66","doi-asserted-by":"publisher","first-page":"17438","DOI":"10.1038\/srep17438","volume":"5","author":"HC Hung","year":"2015","unstructured":"Hung, H.C., F.H. Lu, H.T. Wu, H.Y. Ou, Y.C. Yang, J.S. Wu, and C.J. Chang. 2015. Cardiotrophin-1 is inversely associated with obesity in non-diabetic individuals. Scientific Reports 5: 17438. \nhttps:\/\/doi.org\/10.1038\/srep17438\n\n.","journal-title":"Scientific Reports"},{"issue":"1","key":"959_CR67","doi-asserted-by":"publisher","first-page":"E52","DOI":"10.1152\/ajpendo.00506.2007","volume":"294","author":"C Natal","year":"2008","unstructured":"Natal, C., M.A. Fortuno, P. Restituto, A. Bazan, I. Colina, J. Diez, and N. Varo. 2008. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. American Journal of Physiology. Endocrinology and Metabolism 294 (1): E52\u2013E60. \nhttps:\/\/doi.org\/10.1152\/ajpendo.00506.2007\n\n.","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"10","key":"959_CR68","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.metabol.2013.05.011","volume":"62","author":"T Rendo-Urteaga","year":"2013","unstructured":"Rendo-Urteaga, T., S. Garcia-Calzon, E. Martinez-Anso, M. Chueca, M. Oyarzabal, M.C. Azcona-Sanjulian, M. Bustos, M.J. Moreno-Aliaga, J.A. Martinez, and A. Marti. 2013. Decreased cardiotrophin-1 levels are associated with a lower risk of developing the metabolic syndrome in overweight\/obese children after a weight loss program. Metabolism 62 (10): 1429\u20131436. \nhttps:\/\/doi.org\/10.1016\/j.metabol.2013.05.011\n\n.","journal-title":"Metabolism"},{"issue":"19","key":"959_CR69","doi-asserted-by":"publisher","first-page":"8641","DOI":"10.1073\/pnas.88.19.8641","volume":"88","author":"TM Rose","year":"1991","unstructured":"Rose, T.M., and A.G. Bruce. 1991. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proceedings of the National Academy of Sciences of the United States of America 88 (19): 8641\u20138645.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"959_CR70","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1006\/geno.1993.1294","volume":"17","author":"TM Rose","year":"1993","unstructured":"Rose, T.M., M.J. Lagrou, I. Fransson, B. Werelius, O. Delattre, G. Thomas, P.J. de Jong, G.J. Todaro, and J.P. Dumanski. 1993. The genes for oncostatin M (OSM) and leukemia inhibitory factor (LIF) are tightly linked on human chromosome 22. Genomics 17 (1): 136\u2013140. \nhttps:\/\/doi.org\/10.1006\/geno.1993.1294\n\n.","journal-title":"Genomics"},{"issue":"3","key":"959_CR71","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1182\/blood.V93.3.804","volume":"93","author":"M Tanaka","year":"1999","unstructured":"Tanaka, M., T. Hara, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, and A. Miyajima. 1999. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit. Blood 93 (3): 804\u2013815.","journal-title":"Blood"},{"issue":"2","key":"959_CR72","doi-asserted-by":"publisher","first-page":"E217","DOI":"10.1210\/jc.2013-3555","volume":"99","author":"D Sanchez-Infantes","year":"2014","unstructured":"Sanchez-Infantes, D., U.A. White, C.M. Elks, R.F. Morrison, J.M. Gimble, R.V. Considine, A.W. Ferrante, E. Ravussin, and J.M. Stephens. 2014. Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism 99 (2): E217\u2013E225. \nhttps:\/\/doi.org\/10.1210\/jc.2013-3555\n\n.","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"30","key":"959_CR73","doi-asserted-by":"publisher","first-page":"21861","DOI":"10.1074\/jbc.M113.461905","volume":"288","author":"T Komori","year":"2013","unstructured":"Komori, T., M. Tanaka, E. Senba, A. Miyajima, and Y. Morikawa. 2013. Lack of oncostatin M receptor beta leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype. The Journal of Biological Chemistry 288 (30): 21861\u201321875. \nhttps:\/\/doi.org\/10.1074\/jbc.M113.461905\n\n.","journal-title":"The Journal of Biological Chemistry"},{"issue":"20","key":"959_CR74","doi-asserted-by":"publisher","first-page":"13821","DOI":"10.1074\/jbc.M113.542399","volume":"289","author":"T Komori","year":"2014","unstructured":"Komori, T., M. Tanaka, E. Senba, A. Miyajima, and Y. Morikawa. 2014. Deficiency of oncostatin M receptor beta (OSMRbeta) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice. The Journal of Biological Chemistry 289 (20): 13821\u201313837. \nhttps:\/\/doi.org\/10.1074\/jbc.M113.542399\n\n.","journal-title":"The Journal of Biological Chemistry"},{"issue":"8","key":"959_CR75","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1007\/s00125-015-3613-9","volume":"58","author":"T Komori","year":"2015","unstructured":"Komori, T., M. Tanaka, H. Furuta, T. Akamizu, A. Miyajima, and Y. Morikawa. 2015. Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice. Diabetologia 58 (8): 1868\u20131876. \nhttps:\/\/doi.org\/10.1007\/s00125-015-3613-9\n\n.","journal-title":"Diabetologia"},{"issue":"3","key":"959_CR76","first-page":"395","volume":"13","author":"K Hattori","year":"2004","unstructured":"Hattori, K., T. Sumi, T. Yasui, M. Morimura, H. Nobeyama, E. Okamoto, M. Noriyuki, K. Honda, H. Kiyama, and O. Ishiko. 2004. VEGF mRNA in adipocytes increase with rebound weight-gain after diet-restriction. International Journal of Molecular Medicine 13 (3): 395\u2013399.","journal-title":"International Journal of Molecular Medicine"},{"issue":"7","key":"959_CR77","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1161\/ATVBAHA.107.143081","volume":"27","author":"G. Rega","year":"2007","unstructured":"Rega, G., C. Kaun, S. Demyanets, S. Pfaffenberger, K. Rychli, P.J. Hohensinner, S.P. Kastl, W.S. Speidl, T.W. Weiss, J.M. Breuss, A. Furnkranz, P. Uhrin, J. Zaujec, V. Zilberfarb, M. Frey, R. Roehle, G. Maurer, K. Huber, and J. Wojta. 2007. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology 27 (7): 1587\u20131595. \nhttps:\/\/doi.org\/10.1161\/atvbaha.107.143081\n\n.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"49","key":"959_CR78","doi-asserted-by":"publisher","first-page":"37913","DOI":"10.1074\/jbc.M606089200","volume":"281","author":"Yuichiro Miyaoka","year":"2006","unstructured":"Miyaoka, Y., M. Tanaka, T. Naiki, and A. Miyajima. 2006. Oncostatin M inhibits adipogenesis through the RAS\/ERK and STAT5 signaling pathways. The Journal of Biological Chemistry 281 (49): 37913\u201337920. \nhttps:\/\/doi.org\/10.1074\/jbc.M606089200\n\n.","journal-title":"Journal of Biological Chemistry"},{"issue":"Pt 1","key":"959_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20030407","volume":"374","author":"PC Heinrich","year":"2003","unstructured":"Heinrich, P.C., I. Behrmann, S. Haan, H.M. Hermanns, G. Muller-Newen, and F. Schaper. 2003. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. The Biochemical Journal 374 (Pt 1): 1\u201320. \nhttps:\/\/doi.org\/10.1042\/bj20030407\n\n.","journal-title":"The Biochemical Journal"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-019-00959-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-00959-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-00959-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T19:05:30Z","timestamp":1579374330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-019-00959-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,19]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["959"],"URL":"https:\/\/doi.org\/10.1007\/s10753-019-00959-6","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,19]]},"assertion":[{"value":"19 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}